Search details
1.
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
Blood
; 139(24): 3546-3557, 2022 06 16.
Article
in English
| MEDLINE | ID: mdl-35286378
2.
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.
Blood
; 135(24): 2182-2191, 2020 06 11.
Article
in English
| MEDLINE | ID: mdl-32478814
3.
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation.
N Engl J Med
; 379(19): 1846-1850, 2018 11 08.
Article
in English
| MEDLINE | ID: mdl-30403942
4.
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(3): 529-539, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31678537
5.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32062061
6.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781289
7.
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
Biol Blood Marrow Transplant
; 26(3): 472-479, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31669399
8.
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood
; 131(25): 2816-2825, 2018 06 21.
Article
in English
| MEDLINE | ID: mdl-29724895
9.
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Blood
; 131(25): 2836-2845, 2018 06 21.
Article
in English
| MEDLINE | ID: mdl-29549175
10.
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Blood
; 131(12): 1372-1379, 2018 03 22.
Article
in English
| MEDLINE | ID: mdl-29437593
11.
Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(1): 137-144, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30081073
12.
Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
N Engl J Med
; 375(2): 143-53, 2016 Jul 14.
Article
in English
| MEDLINE | ID: mdl-27410923
13.
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
Blood
; 129(15): 2186-2197, 2017 04 13.
Article
in English
| MEDLINE | ID: mdl-28151427
14.
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.
Blood
; 130(26): 2889-2899, 2017 12 28.
Article
in English
| MEDLINE | ID: mdl-29138220
15.
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(11): 2344-2353, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29758394
16.
A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Biol Blood Marrow Transplant
; 24(8): 1733-1740, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29555313
17.
Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
Biol Blood Marrow Transplant
; 24(11): 2216-2223, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30006305
18.
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant
; 24(3): 581-586, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29032274
19.
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.
Biol Blood Marrow Transplant
; 24(3): 514-520, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29196080
20.
Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.
Blood
; 127(20): 2489-97, 2016 05 19.
Article
in English
| MEDLINE | ID: mdl-26944544